Major hedge funds including Tiger Global Management and Adage Capital Partners reduced their exposure to leading AI stocks such as Nvidia, Amazon, and Microsoft in the fourth quarter of 2025, according to newly released U.S. Securities and Exchange Commission 13-F filings. The disclosures highlight growing investor caution around the “Magnificent 7” tech giants amid concerns that elevated valuations and aggressive AI spending may not deliver expected returns.
Tiger Global trimmed its Microsoft holdings from 6.5 million shares in late September to 5.47 million shares by December 31, though the position still represents approximately $2.6 billion, keeping the hedge fund among Microsoft’s largest shareholders. The firm also cut its Amazon stake by 9.35% to 10 million shares, valued at $2.3 billion, and reduced its Nvidia position, now worth about $2.1 billion.
Other institutional investors made similar portfolio adjustments following the massive rally in AI-related stocks over recent years. Berkshire Hathaway disclosed it sold 4% of its Apple holdings and sharply reduced its Amazon position by 77% during the quarter, although Apple remains its largest investment at $62 billion.
Adage Capital reported modest reductions of 1% to 3% in Microsoft, Alphabet, Amazon, and Nvidia, while increasing its Oracle stake by roughly 19% to 1.87 million shares, valued at $365 million. Meanwhile, SoftBank Group liquidated its Nvidia holdings in October to fund further investments in OpenAI, the creator of ChatGPT. Since SoftBank’s disclosure in November, Nvidia shares have declined around 7%, even as analysts project a 67% year-over-year revenue surge ahead of its February 25 earnings report.
Nvidia’s own 13-F filing revealed a 214.8 million-share stake in Intel as part of a collaboration on PC and data center chips. D.E. Shaw also reduced positions in Nvidia, Micron, and Meta, while adding to Amazon and AMD.
The latest SEC filings suggest institutional investors remain selective in AI stock investments as debate over a potential AI bubble continues to intensify.


Trump Administration Plans New Drug Pricing Deals With Biotech Firms
PayPal Shares Sink as $50 Billion Takeover Bid Collapses
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation
Jefferies Names AMEC Top China Semiconductor Equipment Pick
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition
Amazon Secures 200 MW Wind Power Deals in Sweden
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook
OpenAI AI Agent Swarm Behind Hugging Face Hack
Honda, Nissan Eye Shared Vehicle Software Platform by 2029
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
Meta, U.S. States Discuss Settlement in Teen Addiction Trial
SoftBank Plans Record $6.3 Billion Bond Sale to Fund OpenAI Investments
Luxshare Shares Rise as First-Half Profit Jumps 18%
Yindjibarndi Appeals Fortescue Mining Compensation Ruling
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 



